Bremen, April 22, 2015 – MeVis Medical Solutions AG [ISIN: DE000A0LBFE4], a leading provider of medical imaging software, raises its forecast for the present fiscal year due to the sale of treasury shares:
- For the end of 2015 another increase in liquidity is expected to now € 22.0 to 23.0 m mainly due to the additional liquidity from yesterday’s completed sale of treasury shares (previous forecast: € 20.0 to 21.0 m).
- For 2015 revenues are expected to remain stable at between € 13.0 and 13.5 m (as in the previous forecast).
- For the EBIT (earnings before interest and taxes), a decrease over the previous year to € 2.0 to 2.5 million continues to be expected (as in the previous forecast).